| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1985.01790290073008 |
| P698 | PubMed publication ID | 4004501 |
| P50 | author | Wayne A Bowers | Q59678770 |
| Bruce Pfohl | Q60449053 | ||
| P2093 | author name string | M Zimmerman | |
| C Corenthal | |||
| D Stangl | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 591-596 | |
| P577 | publication date | 1985-06-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | A structured interview for the DSM-III personality disorders. A preliminary report | |
| P478 | volume | 42 |
| Q71109638 | A comparison of DSM-III-R and ICD-10 personality disorder criteria in an out-patient population |
| Q34099626 | Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. |
| Q52014600 | An empirical investigation of the ‘Biopsychosocial Disease Consequence Model’: Psychological impairment, disability and handicap in chronic pain patients |
| Q43511353 | An epidemiological study of histrionic personality disorder. |
| Q50862075 | Axis II comorbidity of borderline personality disorder. |
| Q77327859 | Behavioral assessment of personality disorders |
| Q36196614 | Cerebellar development in childhood onset schizophrenia and non-psychotic siblings |
| Q48008710 | Children of parents with obsessive-compulsive disorder -- a 2-year follow-up study. |
| Q43479116 | Comorbidity of axis I and axis II disorders |
| Q30850987 | Comparing fractional anisotropy in patients with childhood-onset schizophrenia, their healthy siblings, and normal volunteers through DTI |
| Q73795258 | Contrasts between admitters and deniers of drug use |
| Q70731391 | DSM-III-R personality disorders in outpatients with non-bipolar depression: the frequency in a sample of Japanese and the relationship to the 4-month outcome under adequate antidepressant therapy |
| Q41143425 | DSM-III-R personality disorders in panic and obsessive-compulsive disorder: A comparison study |
| Q35643872 | Diagnosis and treatment of personality disorders |
| Q57040229 | Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review |
| Q48683716 | Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder |
| Q48773880 | Divergences between clinical and research methods for assessing personality disorders: implications for research and the evolution of axis II |
| Q34140943 | Epidemiology of personality disorders |
| Q50800077 | Eye tracking, schizophrenic symptoms, and schizotypal personality disorder. |
| Q67861997 | Factor structure of DSM-III-R personality disorders shown by self-report questionnaire: implications for classifying and assessing personality disorders |
| Q24803527 | Functioning styles of personality disorders and five-factor normal personality traits: a correlation study in Chinese students |
| Q72106491 | Gender differences in personality disorders |
| Q28376198 | Genetic antecedents of dopamine dysfunction in schizophrenia |
| Q33906350 | Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. |
| Q51156594 | Growth hormone responses to intravenous clonidine challenge correlate with behavioral irritability in psychiatric patients and healthy volunteers |
| Q35786372 | Hippocampal volume development in healthy siblings of childhood-onset schizophrenia patients |
| Q46744866 | How do eating disorders and alcohol use disorder influence each other? |
| Q72590489 | Inter-rater and temporal reliability of the Standardized Assessment of Personality and the influence of informant characteristics |
| Q41869407 | Interrater reliability of the structured clinical interview for DSM-III-R, Axis II: Schizophrenia spectrum and affective spectrum disorders |
| Q48527936 | Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders |
| Q41118192 | MCMI-II personality disorders in recent-onset bipolar disorders |
| Q68213109 | Measurement of abnormal personality: a review |
| Q57697281 | Measures of Distress in 26 “Environmentally Ill” Subjects |
| Q37634031 | Methodological considerations treatment trials for persons personality disorder |
| Q41152563 | Morbidity risk for mood disorders in the families of borderline patients |
| Q34115534 | Multiple chemical sensitivity: a review of the theoretical and research literature |
| Q35786727 | Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia |
| Q67952519 | Occurrence of schizotypal and borderline symptoms in parasuicide patients: comparison between subjective and objective indices |
| Q34108264 | Personality disorders in late life |
| Q40152279 | Personality pathology and substance abuse in eating disorders: a longitudinal study |
| Q73193794 | Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment |
| Q69002582 | Problems in the classification of personality disorder |
| Q50870576 | Prolactin response to D-fenfluramine in outpatients with major depression. |
| Q68214952 | Rates of Obsessive Compulsive Disorder in First Degree Relatives of Patients with Trichotillomania: a Research Ndte |
| Q48591850 | Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder |
| Q74507731 | Reliability of self-reported antisocial personality disorder symptoms among substance abusers |
| Q71793979 | Schizophrenia susceptibility and chromosome 6p24-22 |
| Q73176230 | Serotonergic function and self-injurious behavior in personality disorder patients |
| Q74176260 | Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness |
| Q50951658 | Social competence in opiate-addicted individuals: gender differences, relationship to psychiatric diagnoses, and treatment response. |
| Q51877500 | Subclinical obsessive-compulsive disorder in children and adolescents: additional results from a "high-risk" study. |
| Q45006000 | The Munich Diagnostic Checklist for the assessment of DSM-III-R Personality Disorders for use in routine clinical care and research |
| Q51910156 | The Personality Disorders Institute/Borderline Personality Disorder Research Foundation Randomized Control Trial for Borderline Personality Disorder: reliability of Axis I and II diagnoses. |
| Q67860802 | The Personality Inventory Scales: A Self-Rating Clinical Instrument for Diagnosis of Personality Disorder |
| Q51949363 | The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. |
| Q60630293 | The efficacy of the Personality Diagnostic Questionnaire-revised as a diagnostic screening instrument in an anxiety disorder group |
| Q74735095 | The impact of personality disorders on treatment outcome of anxiety disorders: best-evidence synthesis |
| Q35682580 | The prevalence of borderline personality disorder among individuals with obesity: a critical review of the literature |
| Q31870842 | The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients |
| Q36813086 | Unidirectionality Between Borderline Personality Disorder Traits and Psychopathology in a Residential Addictions Sample: A Short-Term Longitudinal Study |
| Q52055003 | Use of the ICD-10 version of the Standardized Assessment of Personality to determine the prevalence of personality disorder in psychiatric in-patients. |
| Q52001964 | Validity of the family history method for identifying schizophrenia-related disorders. |
| Q48591841 | Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging |
Search more.